June is a business executive with over 20 years of experience working in the pharma industry in a variety of markets including the United States, China and Asia. Prior to founding NeuroFront, June had multiple key leadership roles in pharma MNCs and biotech companies including 17 years in Eli Lilly (China VP, CNS and Bio-Medicines BU head, Asia Marketing Director, HK GM, US CNS district sales manager), Celgene (China GM) and BeiGene (SVP, China Commercial GM). June has brought to NeuroFront in-depth commercial experiences spanning the entire life cycle of some of the top neuroscience brands (Cymbalta, Zyprexa, Prozac, Strattera, and Symbyax), as well as a proven track record in building and growing successful organizations and leading turn-arounds.
June holds an MBA and an M.S. degree in Biochemistry, both from the University of Maryland (US), and a B.S. degree in Polymer Engineering from Shanghai Jiao Tong University (China).